The Positive Airway Pressure Devices market is anticipated to grow from US$ 6.29 billion in 2023 and is projected to reach US$ 10.54 billion by 2031; it is expected to register a CAGR of 6.7% during 2023-2031. The increasing demand for positive airway pressure devices and the growing shift toward home healthcare are contributing to the growing positive airway pressure devices market size. However, product recall hampers the market growth. Further, technological advancements in positive airway pressure devices are expected to bring in new market trends in the coming years.
North America dominated the market in 2023. The US is the largest and fastest-growing market for positive airway pressure devices. It is estimated to dominate the global market during the forecast period. The PAP devices market growth in the US is driven by the availability of advanced healthcare infrastructure, an increase in the number of sleep apnea disorders, and innovative products introduced by key players operating in the market. Several innovative products are being introduced in the market by the key players to treat sleep apnea. For instance, ResMed offers a wide range of devices for sleep apnea, such as AirMini, AirSense 10 CPAP, and AirSense 10 Elite. The company also sponsors various studies for the treatment of sleep apnea.
Further, the PAP devices market in the US is anticipated to grow during the forecast period owing to the rising approval of technologically advanced products in the market. For instance, in April 2024, researchers at the University of Cincinnati developed a new solution and technology called VortexPAP. It uses a different type of airflow and offers various fits for the device.
The rising prevalence of obstructive sleep apnea and the growing geriatric population in Canada propel the demand for PAP devices in the country. According to the Conference Board of Canada, the percentage of seniors in the Canadian population will rise from 16.9% in 2018 to 21.0% by 2028. Obstructive sleep apnea is a common disorder reported among elderly people; thus, there is significant demand for PAP devices in Canada to treat the condition.
Further, government and private organizations are providing financial assistance to reduce the price barrier and promote PAP therapy. For instance, the Winnipeg Regional Health Authority does co-payment for CPAP therapy equipment. New and replacement CPAP machines will cost patients US$ 500. This co-payment model will lead to savings of nearly US$ 4.9 million annually for the health authority in Canada.
Similarly, the Ministry of Health and long-term care-assistive devices program covers CPAP machines and equipment costs. Canadian Home Healthcare Inc. is among the various organizations in Canada that provide financial assistance for the purchase of CPAP devices. These initiatives undertaken by the Canadian government, as well as the prevalence of sleep disorders in the country, are expected to drive the market of PAP devices during the forecast period.
The need for PAP devices is rising due to the campaigns promoting early detection and treatment. Patients and healthcare professionals are paying more attention as the value of sleep health becomes more widely recognized. The market for PAP devices is growing as more people are taking initiatives to look for ways to enhance the quality of their sleep.
For example, the American Lung Association launched a campaign in November 2022 to raise awareness for COPD and the urgent need to enhance early diagnosis, screening, and quality of life for those with the illness. The sales of PAP devices are expected to rise significantly due to increasing awareness of COPD and other respiratory diseases. To encourage people to monitor the quality of sleep, ResMed runs the "Awaken Your Best" campaign. ResMed hopes to raise awareness of sleep treatment and helpful tools for treating sleep disorders through this campaign. The national "More than a Snore" campaign was started in February 2023 to increase awareness of obstructive sleep apnea.
This chronic illness causes the upper airway to collapse while sleeping. In 2021, the National Center for Chronic Disease Prevention and Health Promotion of the Centers for Disease Control and Prevention offered the American Academy of Sleep Medicine a grant, which was used to fund the collaborative effort. Thus, an increase in awareness of respiratory diseases is likely to create lucrative opportunities in the market.
Eurostat, Statistics Poland, National Library of Medicine, National Institute of Population and Social Security Research, Australian Institute of Health and Welfare, Deloitte Access Economics (Deloitte), National Center for Biotechnology Information (NCBI), Lancet Journal, United Nations Population Fund, Pan American Health Organization, and Centers for Disease Control and Prevention (CDC), are among the primary and secondary sources referred to while preparing the positive airway pressure devices market report.
North America dominated the market in 2023. The US is the largest and fastest-growing market for positive airway pressure devices. It is estimated to dominate the global market during the forecast period. The PAP devices market growth in the US is driven by the availability of advanced healthcare infrastructure, an increase in the number of sleep apnea disorders, and innovative products introduced by key players operating in the market. Several innovative products are being introduced in the market by the key players to treat sleep apnea. For instance, ResMed offers a wide range of devices for sleep apnea, such as AirMini, AirSense 10 CPAP, and AirSense 10 Elite. The company also sponsors various studies for the treatment of sleep apnea.
Further, the PAP devices market in the US is anticipated to grow during the forecast period owing to the rising approval of technologically advanced products in the market. For instance, in April 2024, researchers at the University of Cincinnati developed a new solution and technology called VortexPAP. It uses a different type of airflow and offers various fits for the device.
The rising prevalence of obstructive sleep apnea and the growing geriatric population in Canada propel the demand for PAP devices in the country. According to the Conference Board of Canada, the percentage of seniors in the Canadian population will rise from 16.9% in 2018 to 21.0% by 2028. Obstructive sleep apnea is a common disorder reported among elderly people; thus, there is significant demand for PAP devices in Canada to treat the condition.
Further, government and private organizations are providing financial assistance to reduce the price barrier and promote PAP therapy. For instance, the Winnipeg Regional Health Authority does co-payment for CPAP therapy equipment. New and replacement CPAP machines will cost patients US$ 500. This co-payment model will lead to savings of nearly US$ 4.9 million annually for the health authority in Canada.
Similarly, the Ministry of Health and long-term care-assistive devices program covers CPAP machines and equipment costs. Canadian Home Healthcare Inc. is among the various organizations in Canada that provide financial assistance for the purchase of CPAP devices. These initiatives undertaken by the Canadian government, as well as the prevalence of sleep disorders in the country, are expected to drive the market of PAP devices during the forecast period.
Mexico 127.6 2.85 6.8
Further, hospital San Jose Tec De Monterrey, Galenia Hospital, and San Angel Hospital are among the hospitals in Mexico that provide treatments for sleep apnea disorders. These hospitals use PAP devices for the treatment of sleep-related disorders. Factors such as the prevalence of asthma and the rising geriatric population are expected to lead to significant demand for PAP devices in Mexico and propel its market during the forecast period.Increasing Awareness of Respiratory Diseases to Creates Market Opportunities in Future
More people are seeking medical attention for sleep problems as awareness grows. As a result, disorders such as OSA are being diagnosed more frequently and treated with machines that provide CPAP or BiPAP. Government and medical institutions frequently conduct public awareness campaigns for the risks of untreated sleep apnea leading to diabetes and cardiovascular problems.The need for PAP devices is rising due to the campaigns promoting early detection and treatment. Patients and healthcare professionals are paying more attention as the value of sleep health becomes more widely recognized. The market for PAP devices is growing as more people are taking initiatives to look for ways to enhance the quality of their sleep.
For example, the American Lung Association launched a campaign in November 2022 to raise awareness for COPD and the urgent need to enhance early diagnosis, screening, and quality of life for those with the illness. The sales of PAP devices are expected to rise significantly due to increasing awareness of COPD and other respiratory diseases. To encourage people to monitor the quality of sleep, ResMed runs the "Awaken Your Best" campaign. ResMed hopes to raise awareness of sleep treatment and helpful tools for treating sleep disorders through this campaign. The national "More than a Snore" campaign was started in February 2023 to increase awareness of obstructive sleep apnea.
This chronic illness causes the upper airway to collapse while sleeping. In 2021, the National Center for Chronic Disease Prevention and Health Promotion of the Centers for Disease Control and Prevention offered the American Academy of Sleep Medicine a grant, which was used to fund the collaborative effort. Thus, an increase in awareness of respiratory diseases is likely to create lucrative opportunities in the market.
Positive Airway Pressure Devices Market: Competitive Landscape and Key Developments
ICU Medical Inc, React Health (Formely 3B Medical, Inc), Fisher & Paykel Healthcare Corp Ltd, BPL Medical Technologies Pvt Ltd, Koninklijke Philips NV, ResMed Inc, Vyaire Medical Inc, Wellell Inc, Armstrong Medical Ltd, Löwenstein Medical UK Ltd., BMC Medical Co Ltd, Dragerwerk AG & Co KGaA, and Narang Medical Limited are among the key companies operating in the positive airway pressure devices market.Eurostat, Statistics Poland, National Library of Medicine, National Institute of Population and Social Security Research, Australian Institute of Health and Welfare, Deloitte Access Economics (Deloitte), National Center for Biotechnology Information (NCBI), Lancet Journal, United Nations Population Fund, Pan American Health Organization, and Centers for Disease Control and Prevention (CDC), are among the primary and secondary sources referred to while preparing the positive airway pressure devices market report.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Positive Airway Pressure (PAP) Devices Market Landscape
5. Positive Airway Pressure (PAP) Devices Market - Key Market Dynamics
6. Positive Airway Pressure (PAP) Devices Market - Global Market Analysis
7. Positive Airway Pressure (PAP) Devices Market Analysis - by Product Type
8. Positive Airway Pressure (PAP) Devices Market Analysis - by Application
9. Positive Airway Pressure (PAP) Devices Market Analysis - by End User
10. Positive Airway Pressure (PAP) Devices Market - Geographical Analysis
11. Positive Airway Pressure Devices Market - Industry Landscape
12. Company Profiles
13. Appendix
Companies Mentioned
- ICU Medical Inc
- React Health (Formely 3B Medical, Inc)
- Fisher & Paykel Healthcare Corp Ltd
- BPL Medical Technologies Pvt Ltd
- Koninklijke Philips NV
- ResMed Inc
- Vyaire Medical Inc
- Wellell Inc
- Armstrong Medical Ltd
- Löwenstein Medical UK Ltd.
- BMC Medical Co Ltd
- Dragerwerk AG & Co KGaA
- Narang Medical Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 168 |
| Published | October 2024 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value ( USD | $ 6.29 Billion |
| Forecasted Market Value ( USD | $ 10.54 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
